Experiences with animal models of dermatitis herpetiformis: A review

References

• Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens. 1997; 49:29–34.
   PubMedGoogle Scholar
• Balas A, Vicario JL, Zambrano A, Acuna D, Garcia-Novo D. Absolute linkage of celiac disease and dermatitis herpetiformis to HLA-DQ. Tissue Antigens. 1997; 50:52–56.
   PubMedGoogle Scholar
• Hall RPIII. Dermatitis herpetiformis. J Invest Dermatol. 1992; 99:873–881.
   PubMed Web of Science ®Google Scholar
• Alonso-Llamazares J, Gibson LE, Rogers RSIII. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: Review of the Mayo Clinic experience. Int J Dermatol. 2007; 46:910–919.
   PubMed Web of Science ®Google Scholar
• Nicolas ME, Krause PK, Gibson LE, Murray JA. Dermatitis herpetiformis. Int J Dermatol. 2003; 42:588–600.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr Dir Autoimmun. 2008; 10:344–358.
   PubMedGoogle Scholar
• Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology. 1993; 105:910–922.
   PubMed Web of Science ®Google Scholar
• Reunala TL. Dermatitis herpetiformis. Clin Dermatol. 2001; 19:728–736.
   PubMed Web of Science ®Google Scholar
• Savilahti E, Reunala T, Maki M. Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut. 1992; 33:206–211.
   PubMed Web of Science ®Google Scholar
• Caproni M, Cardinali C, Renzi D, Calabro A, Fabbri P. Tissue transglutaminase antibody assessment in dermatitis herpetiformis. Br J Dermatol. 2001; 144:196–197.
   PubMed Web of Science ®Google Scholar
• Peters MS, McEvoy MT. IgA antiendomysial antibodies in dermatitis herpetiformis. J Am Acad Dermatol. 1989; 21:1225–1231.
   PubMed Web of Science ®Google Scholar
• Leonard JN, Griffiths CE, Powles AV, Haffenden GP, Fry L. Experience with a gluten free diet in the treatment of linear IgA disease. Acta Derm Venereol. 1987; 67:145–148.
   PubMed Web of Science ®Google Scholar
• Inomata N. Wheat allergy. Curr Opin Allergy Clin Immunol. 2009; 9:238–243.
   PubMed Web of Science ®Google Scholar
• Michaelsson G, Gerden B, Hagforsen E, Nilsson B, Pihl-Lundin I, Kraaz W, . Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol. 2000; 142:44–51.
   PubMed Web of Science ®Google Scholar
• Batt RM, Carter MW, McLean L. Wheat-sensitive enteropathy in Irish setter dogs: possible age-related brush border abnormalities. Res Vet Sci. 1985; 39:80–83.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Carter SD, Barnes A, Batt RM. Immune responses to dietary antigens in gluten-sensitive enteropathy of Irish setters. Res Vet Sci. 1992; 53:293–299.
   PubMed Web of Science ®Google Scholar
• Polvi A, Garden OA, Houlston RS, Maki M, Batt RM, Partanen J. Genetic susceptibility to gluten sensitive enteropathy in Irish setter dogs is not linked to the major histocompatibility complex. Tissue Antigens. 1998; 52:543–549.
   PubMed Web of Science ®Google Scholar
• Bethune MT, Borda JT, Ribka E, Liu MX, Phillippi-Falkenstein K, Jandacek RJ, . A non-human primate model for gluten sensitivity. PLoS One. 2008a; 3:e1614.
   PubMed Web of Science ®Google Scholar
• Bethune MT, Ribka E, Khosla C, Sestak K. Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques. PLoS One. 2008b; 3:e1857.
   PubMed Web of Science ®Google Scholar
• Troncone R, Ferguson A. Animal model of gluten induced enteropathy in mice. Gut. 1991; 32:871–875.
   PubMed Web of Science ®Google Scholar
• Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: A model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002; 169:5595–5600.
   PubMed Web of Science ®Google Scholar
• Chen Z, Dudek N, Wijburg O, Strugnell R, Brown L, Deliyannis G, . A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. J Immunol. 2002; 168:3050–3056.
   PubMed Web of Science ®Google Scholar
• Chen D, Ueda R, Harding F, Patil N, Mao Y, Kurahara C, . Characterization of HLA DR3/DQ2 transgenic mice: A potential humanized animal model for autoimmune disease studies. Eur J Immunol. 2003; 33:172–182.
   PubMed Web of Science ®Google Scholar
• Depaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, . Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 2011; 471:220–224.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Marietta E, Cheng S, Camilleri M, Pittelkow M, David C, . Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus. 2010; 19:815–829.
   PubMed Web of Science ®Google Scholar
• Briani C, Samaroo D, Alaedini A. Celiac disease: From gluten to autoimmunity. Autoimmun Rev. 2008; 7:644–650.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Marietta EV, Murray JA. Celiac sprue: A unique autoimmune disorder. Expert Rev Clin Immunol. 2009; 5:593–604.
   PubMed Web of Science ®Google Scholar
• Marietta EV, Rashtak S, Murray JA. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA. World J Gastroenterol. 2009; 15:845–848.
   PubMed Web of Science ®Google Scholar
• Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002; 195:747–757.
   PubMed Web of Science ®Google Scholar
• Kaplan RP, Callen JP. Dermatitis herpetiformis: Autoimmune disease associations. Clin Dermatol. 1991; 9:347–360.
   PubMed Web of Science ®Google Scholar
• Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997; 136:315–318.
   PubMed Web of Science ®Google Scholar
• Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis: Prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985; 102:194–196.
   PubMed Web of Science ®Google Scholar
• Kurano TL, Lum CA, Izumi AK. The association of dermatitis herpetiformis and systemic lupus erythematosus. J Am Acad Dermatol. 2010; 63:892–895.
   PubMed Web of Science ®Google Scholar
• Davies MG, Marks R, Nuki G. Dermatitis herpetiformis: A skin manifestation of a generalized disturbance in immunity. Q J Med. 1978; 47:221–248.
   PubMedGoogle Scholar
• Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, . TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2000; 43:129–134.
   PubMed Web of Science ®Google Scholar
• Vargas-Alarcon G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J, . Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: The relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol. 2001; 62:814–820.
   PubMed Web of Science ®Google Scholar
• Hernandez L, Green PH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep. 2006; 8:383–389.
   PubMedGoogle Scholar
• Guariso G, Conte S, Presotto F, Basso D, Brotto F, Visona Dalla Pozza L, . Clinical, subclinical and potential autoimmune diseases in an Italian population of children with coeliac disease. Aliment Pharmacol Ther. 2007; 26:1409–1417.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: Role of deamidated gliadin antibody. J Neuroimmunol. 2011; 230:130–134.
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008; 64:332–343.
   PubMed Web of Science ®Google Scholar
• Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R, . Anti transglutaminase antibodies cause ataxia in mice. PLoS One. 2010; 5:e9698.
   PubMed Web of Science ®Google Scholar
• Zone JJ, Egan CA, Taylor TB, Meyer LJ. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc. 2004; 9:47–51.
   PubMedGoogle Scholar
• Zone JJ, Schmidt LA, Taylor TB, Hull CM, Sotiriou MC, . Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology. J Immunol. 2011; 186:4474–4480.
   PubMed Web of Science ®Google Scholar
• Marietta E, Black K, Camilleri M, Krause P, Rogers RSIII, David C, . A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest. 2004; 114:1090–1097.
   PubMed Web of Science ®Google Scholar
• Reitamo S, Reunala T, Konttinen YT, Saksela O, Salo OP. Inflammatory cells, IgA, C3, fibrin and fibronectin in skin lesions in dermatitis herpetiformis. Br J Dermatol. 1981; 105:167–177.
   PubMed Web of Science ®Google Scholar
• Baker BS, Garioch JJ, Bokth S, Leonard J, Fry L. Absence of gluten-specific T lymphocytes in the skin of patients with dermatitis herpetiformis. J Autoimmun. 1995; 8:75–82.
   PubMed Web of Science ®Google Scholar
• Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol. 2008; 128:332–335.
   PubMed Web of Science ®Google Scholar
• Jaskowski TD, Hamblin T, Wilson AR, Hill HR, Book LS, Meyer LJ, . IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease. J Invest Dermatol. 2009; 129:2728–2730.
   PubMed Web of Science ®Google Scholar
• Elliott JF, Liu J, Yuan ZN, Bautista-Lopez N, Wallbank SL, Suzuki K, . Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci U S A. 2003; 100:13447–13452.
   PubMed Web of Science ®Google Scholar
• Taneja V, Behrens M, Cooper LT, Yamada S, Kita H, Redfield MM, . Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol. 2007; 42:1054–1064.
   PubMed Web of Science ®Google Scholar
• Taneja V, David CS. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. J Autoimmun. 2009; 33:260–269.
   PubMed Web of Science ®Google Scholar
• Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, . Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996; 135:363–367.
   PubMed Web of Science ®Google Scholar
• Hervonen K, Vornanen M, Kautiainen H, Collin P, Reunala T. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2005; 152:82–86.
   PubMed Web of Science ®Google Scholar
• Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992; 98:135–140.
   PubMed Web of Science ®Google Scholar
• Miyachi Y. Pharmacologic modulation of neutrophil functions. Clin Dermatol. 2000; 18:369–373.
   PubMed Web of Science ®Google Scholar
• Thuong-Nguyen V, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of neutrophil adherence to antibody by dapsone: A possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol. 1993; 100:349–355.
   PubMed Web of Science ®Google Scholar
• Smith AD, Streilein RD, Hall RPIII. Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis. Br J Dermatol. 2002; 147:1109–1117.
   PubMed Web of Science ®Google Scholar
• Caproni M, Antiga E, Melani L, Fabbri P. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009; 23:633–638.
   PubMed Web of Science ®Google Scholar
• Leonard JN, Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol. 1991; 9:403–408.
   PubMed Web of Science ®Google Scholar
• Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: A guide for dermatologists. Am J Clin Dermatol. 2003; 4:13–20.
   PubMed Web of Science ®Google Scholar
• Fleischer ABJr, Shalita A, Eichenfield LF, Abramovits W, Lucky A, Garrett S. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: A 12-week, randomized, double-blind study. J Drugs Dermatol. 2010; 9:33–40.
   PubMed Web of Science ®Google Scholar
• Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, . Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol. 2009; 183:2390–2396.
   PubMed Web of Science ®Google Scholar
• Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, . Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000; 289:1352–1355.
   PubMed Web of Science ®Google Scholar
• Senger S, Luongo D, Maurano F, Mazzeo MF, Siciliano RA, Gianfrani C, . Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett. 2003; 88:127–134.
   PubMed Web of Science ®Google Scholar
• Marietta E, Pittelkow M, David C, Murray J. Intranasal gliadin peptide therapy and oral feeding with gluten inhibits blistering in a mouse model of dermatitis herpetiformis. Clinical Immunol. 2006; 119:S46.
   Web of Science ®Google Scholar
• Xia J, Bergseng E, Fleckenstein B, Siegel M, Kim CY, Khosla C, . Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorg Med Chem. 2007; 15:6565–6573.
   PubMed Web of Science ®Google Scholar
• Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vezina A, Rivard N, . Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology. 2009; 136:288–298.
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Andre C, Joneau Fabre M, Lauret P, Flechet ML, Kalis B, . Plasma exchange in pemphigus: Uncontrolled study of ten patients. Arch Dermatol. 1983; 119:215–221.
   PubMedGoogle Scholar
• Tan-Lim R, Bystryn JC. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol. 1990; 22:35–40.
   PubMed Web of Science ®Google Scholar
• Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 2000; 43:1058–1064.
   PubMed Web of Science ®Google Scholar
• Guillaume JC, Roujeau JC, Morel P, Doutre MS, Guillot B, Lambert D, . Controlled study of plasma exchange in pemphigus. Arch Dermatol. 1988; 124:1659–1663.
   PubMedGoogle Scholar
• Kasperkiewicz M, Schmidt E. Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol. 2009; 6:270–280.
   PubMedGoogle Scholar
• Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, . Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases. J Dtsch Dermatol Ges. 2007; 5:881–887.
   PubMedGoogle Scholar
• Cooper HL, Healy E, Theaker JM, Friedmann PS. Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (rituximab). Clin Exp Dermatol. 2003; 28:366–368.
   PubMed Web of Science ®Google Scholar
• Dupuy A, Viguier M, Bedane C, Cordoliani F, Blaise S, Aucouturier F, . Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol. 2004; 140:91–96.
   PubMed Web of Science ®Google Scholar
• Kasperkiewicz M, Zillikens D. Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases. Hautarzt. 2007; 58:115–126, 8-21.
   PubMed Web of Science ®Google Scholar
• Kong HH, Prose NS, Ware RE, Hall RPIII. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol. 2005; 22:461–464.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Hennig K, Mengede C, Zillikens D, Kromminga A. Immunogenicity of rituximab in patients with severe pemphigus. Clin Immunol. 2009; 132:334–341.
   PubMed Web of Science ®Google Scholar
• Bruno O, Brullo C, Bondavalli F, Schenone S, Spisani S, Falzarano MS, . 1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazol e-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors. Bioorg Med Chem. 2009; 17:3379–3387.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ, . A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest. 2000; 105:113–123.
   PubMed Web of Science ®Google Scholar
• Hall RPIII, Owen S, Smith A, Keough M, Bagheri B, Church P, . TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy: Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy. Exp Dermatol. 2000; 9:275–282.
   PubMed Web of Science ®Google Scholar